Results
115
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
115 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
81X | HK$0.14 | 12.1% | -47.3% | HK$7.3b | n/a | PE26.4x | E29.5% | 0% | ||
3YV | JP¥23.00 | 7.5% | -25.3% | JP¥124.6b | JP¥32.39 | PE46.3x | E30.4% | n/a | ||
I1D | HK$1.60 | 0% | n/a | HK$6.5b | HK$2.16 | PS3.4x | E141.5% | n/a | ||
K0U | HK$0.96 | 10.9% | -45.8% | HK$6.3b | HK$1.24 | PE25.5x | E23.2% | n/a | ||
6YZ | HK$1.62 | 0% | -48.7% | HK$6.3b | HK$2.92 | PE52.8x | E60.4% | n/a | ||
OQS | AU$2.26 | 4.6% | -9.6% | AU$1.1b | AU$2.11 | PE87.1x | E23.2% | n/a | ||
C26 | SEK 24.95 | 2.9% | 84.5% | SEK 6.8b | SEK 22.73 | PE47x | E24.2% | 0.8% | ||
AQA | UK£2.62 | -9.7% | 15.9% | UK£484.3m | UK£3.12 | PE43.5x | E23.6% | 1.1% | ||
4P41 | SEK 11.13 | 4.4% | n/a | SEK 6.5b | SEK 16.56 | PE32.6x | E32.6% | n/a | ||
LT3 | US$12.20 | -6.2% | 164.1% | US$604.4m | US$14.01 | PS3.5x | E79.4% | n/a | ||
SBS | €43.90 | 3.2% | -0.8% | €533.6m | €43.83 | PE36.6x | E20.0% | 1.3% | ||
SBS | €43.10 | 3.9% | -0.7% | €533.6m | €43.03 | PE36.6x | E20.0% | 1.3% | ||
Z44 | €12.54 | -0.8% | n/a | €496.4m | €16.24 | PE191x | E47.2% | 4.0% | ||
818 | HK$1.39 | 6.1% | 53.6% | HK$4.1b | HK$1.72 | PE143.4x | E69.8% | n/a | ||
PXS | AU$0.26 | 10.3% | n/a | AU$728.3m | n/a | PE86.9x | E35.6% | n/a | ||
5NN | DKK 17.02 | 11.8% | 56.4% | DKK 3.3b | DKK 18.37 | PE45x | E49.9% | 0% | ||
ILM1 | €15.90 | -3.5% | 6.1% | €417.3m | €30.32 | PE26.2x | E40.9% | n/a | ||
ILM1 | €16.36 | 0.7% | 8.5% | €417.3m | €31.20 | PE26.2x | E40.9% | n/a | ||
IOB | €13.14 | -4.6% | 36.3% | €389.3m | €17.70 | PE49.6x | E73.1% | 1.3% | ||
25E | JP¥6.00 | -5.5% | 18.8% | JP¥60.3b | n/a | PE23.3x | E20.8% | 1.4% | ||
A2P | zł44.30 | 11.2% | n/a | zł1.6b | zł46.21 | PE20.3x | E20.0% | 1.6% | ||
MIS | AU$0.73 | 5.8% | -2.7% | AU$475.4m | n/a | PS1.9x | E50.1% | 4.1% | ||
6OVA | CA$5.75 | -0.9% | 184.7% | CA$432.9m | CA$6.53 | PE91.2x | E65.9% | n/a | ||
UG2 | US$6.50 | 0.8% | -4.4% | US$311.3m | US$11.31 | PS1x | E97.8% | n/a |